AVOIDABLE DEATHS FROM ONCOLOGY DISEASE IN AKTOBE REGION
Introduction. Population health is the primary outcome of a health care system. Measuring the performance of a health care system is essential to assessing the effectiveness of existing programs. Therefore, the aim of our study to assess the avoidable deaths from oncological disease in Aktobe region.
Materials and methods: We extracted data from the National research center for health development in Aktobe region by urban and rural area. In calculation population by age; death rates from oncologic diseases from 2019 to 2023, by gender and 5-year age group (0, 1–4, 5–9, 69) were included. Join point regression used to identify the average annual percentage change.
Results. Avoidable deaths from oncological disease decrease from 29.92 to 27.94 per 100000 population during 2019-2023. The preventable deaths from oncological diseases per 100000 populations fluctuated between 17.20 to 17.08, where the peak increase was in 2021 to 19.51, whereas treatable deaths rate decreased from 15.06 to 10.87 in studied years The avoidable deaths was higher among male and rural residents. The absolute changes were for avoidable deaths – 1.98, where preventable was -1.86 and treatable -1.98. Relative changes were -0.07, with the difference between preventable and treatable as -0.11 to -0.01.
Conclusion. The leading causes of avoidable death were colorectal and lung cancer. Despite some reduction in avoidable mortality, it remains high among rural residents and males, which requires studying the causes and developing measures among them.
Dinara Katasheva1, https://orcid.org/0009-0008-5803-5114
Anuar Akhmetzhan2, https://orcid.org/0009-0009-7451-9706
Nurgul Alekenova1, https://orcid.org/0000-0001-5751-1678
Nazgul Akhtayeva2, https://orcid.org/0000-0002-0835-9814
Eleonora Nurbaulina1, https://orcid.org/0000-0003-0124-2848
1 Marat Ospanov West-Kazakhstan Medical University,
Aktobe, Republic of Kazakhstan;
2 Asfendiyarov Kazakh National Medical University,
Almaty, Republic of Kazakhstan.
1. Aaron K.J., Van Der Pol B., Jordan S.J., Schwebke J.R., Hook E.W. Delay in Seeking Health Care Services After Onset of Urethritis Symptoms in Men. Sex Transm Dis. 2019. 46(5): 317-320. doi:10.1097/OLQ.0000000000000976
2. Australian Institute of Health and Welfare. https://www.aihw.gov.au/reports/life-expectancy-death/deaths-in-australia/contents/age-at-death. (Accessed: 09.05.2023)
3. Avoidable mortality: OECD/Eurostat lists of preventable and treatable causes of death (January 2022 version); 2022. Available from: https://www.oecd.org/health/health-systems/Avoidable-mortality-2019-Joint-OECD-Eurostat-List-preventable-treatable-causes-of-death.pdf. (Accessed August 15, 2023).
4. Baker P., Shand T. Men's health: time for a new approach to policy and practice? J Glob Health. 2017 Jun. 7(1):010306. doi: 10.7189/jogh.07.010306.
5. Canadian Institute for Health Information (CIHI). Health Indicators 2012. Ottawa, Ontario: CIHI. 2012. https://secure.cihi.ca/free_products/health_indicators_2012_en.pdf. 10. (Accessed: 05.06.2024)
6. Centers for Disease Control and Prevention (CDC). Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease – United States, 2001–2010. MMWR Morb Mortal Wkly Rep. 2013. 62(35):721–727.
7. Chan B.T., Rauscher C., Issina A.M. et al. A programme to improve quality of care for patients with chronic diseases, Kazakhstan. Bull World Health Organ. 2020. 98(3):161-169. doi:10.2471/BLT.18.227447
8. Chertischeva I.L., Li V.Ye., Bekezhan A.B., Masadykov A.S., Shalgumbayeva G.M., Sajdualiev D.N. Morbidity and mortality rate of breast cancer in Kazakhstan, 2015-2019. Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 2, pp. 148-154. doi 10.34689/SH.2021.23.2.016
9. Currie J., Schilling H.T., Evans L. et al. Contribution of avoidable mortality to life expectancy inequalities in Wales: a decomposition by age and by cause between 2002 and 2020. J Public Health (Oxf). 2023. 45(3):762-770. doi:10.1093/pubmed/fdac133
10. Geng J., Yu X., Bao H. et al. Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review with Cumulative Meta-Analysis. Front Med (Lausanne). 2021. 8:588013. Published 2021 Sep 1. doi:10.3389/fmed.2021.588013
11. Hrzic R., Vogt T. The contribution of avoidable mortality to life expectancy differences and lifespan disparities in the European Union: a population-based study. Lancet Reg Health Eur. 2024 Aug 30.46:101042. doi: 10.1016/j.lanepe.2024.101042.
12. Kosherbayeva L., Samambayeva A., Akhtaeva N., Tolganbayeva K., Imamatdinova A. Treatable mortality in genitourinary system disease. Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 1, pp. 79-85. doi 10.34689/SH.2023.25.1.010
13. Life expectancy at birth of the population of the Republic of Kazakhstan for 2023 Release date: 25.04.2024 https://stat.gov.kz/upload/iblock/5df/cqh3s0div41z8tbt5v23bk67407sj6r8/%D0%91-18-08-%D0%93%20(%D0%B0%D0%BD%D0%B3%D0%BB).pdf (Accessed: 28.06.2024)
14. Ministry of Healthcare of the Republic of Kazakhstan https://www.gov.kz/memleket/entities/dsm?lang=en (Accessed: 22.02.2024.)
15. Nolte E., McKee M. Variations in amenable mortality--trends in 16 high-income nations. Does Health Care Save Lives? 2011. 103(1):47-52. doi:10.1016/j. healthpol.2011.08.002
16. OECD. Avoidable mortality (preventable and treatable). In: Health at a Glance 2019: OECD Indicators. Paris: OECD Publishing; 2019.
17. OECD Health Statistics Definitions, sources and methods; 2022. Available from: https://stats.oecd.org/index.aspx?queryid=96018. (Accessed August 15, 2023).
18. Order of Target Groups of Persons Subject to Screening Studies. As Well As the Rules. Scope and Frequency of These Studies Acting Order Minister of Health of the Republic of Kazakhstan Dated October 30. 2020 No. ҚР ДСМ-174/2020. Registered with the Ministry of Justice of the Republic of Kazakhstan on November 2. 2020 No. 21572. (Kazakh or Russian). https://adilet.zan.kz/rus/docs/V2000021572. (Accessed: 20.06.2024)
19. Rutstein D.D., Berenberg W., Chalmers T.C., Child C.G., Fishman A.P., Perrin E.B. Measuring the quality of medical care. A clinical method. N Engl J Med. 1976. 294(11):582-588. doi:10.1056/nejm197603112941104
20. Santucci C., Carioli G., Bertuccio P., et al. Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev. 2020. 29(5):367-381. doi:10.1097/CEJ.0000000000000594
21. Siegel R.L., Giaquinto A.N., Jemal A. Cancer statistics, 2024 [published correction appears in CA Cancer J Clin. 2024 Mar-Apr. 74(2):203. doi: 10.3322/caac.21830]. CA Cancer J Clin. 2024. 74(1):12-49. doi:10.3322/caac.21820
22. Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021. 71(3):209-249. doi:10.3322/caac.21660
23. Södergren M. Lifestyle predictors of healthy ageing in men. Maturitas. 2013. 75(2):113-117. doi:10.1016/j.maturitas.2013.02.011
24. WHO Primary Health Care Demonstration Platform. Copenhagen: WHO Regional O!ce for Europe. 2022. Licence: CC BY-NC-SA 3.0 IGO. https://iris.who.int/bitstream/handle/10665/363477/WHO-EURO-2022-6221-45986-66438-eng.pdf?sequence=1 (Accessed: 21.05.2024)
25. Wilson L., Bhatnagar P., Townsend N. Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983–2013: joinpoint regression analysis. Popul Health Metr. 2017. 15(1):23. doi: 10.1186/s12963-017-0141-5
Number of Views: 103
Category of articles:
Original article
Bibliography link
Katasheva D., Akhmetzhan A., Alekenova N., Akhtayeva N., Nurbaulina E. Avoidable deaths from oncology disease in Aktobe region // Ғылым және Денсаулық сақтау. 2024. Т.26 (6). Б. 28-37. doi 10.34689/SH.2024.26.6.004Related publications:
THE RELATIONSHIP BETWEEN BODY MASS INDEX AND BONE MINERAL DENSITY IN THE MIDDLE-AGED AND ELDERLY POPULATION
CLINICAL, MORPHOLOGICAL AND MORPHOMETRIC ASSESSMENT OF GRANULOMATOUS INFLAMMATION IN SARCOIDOSIS AND PULMONARY TUBERCULOSIS
DRUG-INDUCED LIVER INJURY IN HIV-INFECTED PATIENTS WITH ACTIVE TUBERCULOSIS: COMPARATIVE LABORATORY CHARACTERIZATION
RESULTS OF THE IMPLEMENTATION OF THE DISEASE MANAGEMENT PROGRAM ON CHRONIC HEART FAILURE IN THE REPUBLIC OF KAZAKHSTAN
COMORBIDITY IN OSTEOARTHRITIS